Principles of human subjects protections applied in an opt-out, de-identified biobank
- PMID:20443953
- PMCID: PMC3075971
- DOI: 10.1111/j.1752-8062.2010.00175.x
Principles of human subjects protections applied in an opt-out, de-identified biobank
Abstract
BioVU, the Vanderbilt DNA Databank, is one of few biobanks that qualifies as non-human subjects research as determined by the local IRB and the federal Office of Human Research Protections (OHRP). BioVU accrues DNA samples extracted from leftover blood remaining from routine clinical testing. The resource is linked to a de-identified version of data extracted from an Electronic Medical Record (EMR) system, termed the Synthetic Device (SD), in which all personal identifiers have been removed. Thus, there is no identifiable private information attached to the records. The Belmont Report enumerates the importance of the boundary between practice and research, and three principles: Respect for Persons, Beneficence, and Justice, which constitute the essential ethical framework by which IRBs and ethics committees judge the risks and benefits of research involving human subjects. BioVU was developed by designing and implementing new procedures, for which there were no previously established methods, which are consistent with the principles of the Belmont Report. These included special oversight and governance, new informatics technologies, provisions to accommodate patients' preferences, as well as an extensive public education and communications component. Considerations of core principles and protections in the practical implementation of BioVU is the focus of this paper.
Figures
Similar articles
- American Society of Clinical Oncology policy statement: oversight of clinical research.American Society of Clinical Oncology.American Society of Clinical Oncology.J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.J Clin Oncol. 2003.PMID:12721281
- The historical, ethical, and legal background of human-subjects research.Rice TW.Rice TW.Respir Care. 2008 Oct;53(10):1325-9.Respir Care. 2008.PMID:18811995
- The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research.Department of Health, Education, and Welfare; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research.Department of Health, Education, and Welfare, et al.J Am Coll Dent. 2014 Summer;81(3):4-13.J Am Coll Dent. 2014.PMID:25951677
- Protection of research subjects with emphasis on protocols involving radiation.Classic KL, Porter BL, DiMagno EP.Classic KL, et al.Health Phys. 2001 May;80(5 Suppl):S70-6. doi: 10.1097/00004032-200105001-00009.Health Phys. 2001.PMID:11316087Review.
- Ethical considerations in psychopharmacological research involving decisionally impaired subjects.Rosenstein DL, Miller FG.Rosenstein DL, et al.Psychopharmacology (Berl). 2003 Dec;171(1):92-7. doi: 10.1007/s00213-003-1503-1. Epub 2003 May 28.Psychopharmacology (Berl). 2003.PMID:12774188Review.
Cited by
- The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients.Birdwell KA, Grady B, Choi L, Xu H, Bian A, Denny JC, Jiang M, Vranic G, Basford M, Cowan JD, Richardson DM, Robinson MP, Ikizler TA, Ritchie MD, Stein CM, Haas DW.Birdwell KA, et al.Pharmacogenet Genomics. 2012 Jan;22(1):32-42. doi: 10.1097/FPC.0b013e32834e1641.Pharmacogenet Genomics. 2012.PMID:22108237Free PMC article.
- DRUG-DRUG INTERACTION PROFILES OF MEDICATION REGIMENS EXTRACTED FROM A DE-IDENTIFIED ELECTRONIC MEDICAL RECORDS SYSTEM.Butkiewicz M, Restrepo NA, Haines JL, Crawford DC.Butkiewicz M, et al.AMIA Jt Summits Transl Sci Proc. 2016 Jul 20;2016:33-40. eCollection 2016.AMIA Jt Summits Transl Sci Proc. 2016.PMID:27570646Free PMC article.
- Phenome-Wide Association Study to Explore Relationships between Immune System Related Genetic Loci and Complex Traits and Diseases.Verma A, Basile AO, Bradford Y, Kuivaniemi H, Tromp G, Carey D, Gerhard GS, Crowe JE Jr, Ritchie MD, Pendergrass SA.Verma A, et al.PLoS One. 2016 Aug 10;11(8):e0160573. doi: 10.1371/journal.pone.0160573. eCollection 2016.PLoS One. 2016.PMID:27508393Free PMC article.
- Functional Analysis of Mouse G6pc1 Mutations Using a Novel In Situ Assay for Glucose-6-Phosphatase Activity and the Effect of Mutations in Conserved Human G6PC1/G6PC2 Amino Acids on G6PC2 Protein Expression.Boortz KA, Syring KE, Pound LD, Wang Y, Oeser JK, O'Brien RM.Boortz KA, et al.PLoS One. 2016 Sep 9;11(9):e0162439. doi: 10.1371/journal.pone.0162439. eCollection 2016.PLoS One. 2016.PMID:27611587Free PMC article.
- Stem cell banking: between traceability and identifiability.Knoppers BM, Isasi R.Knoppers BM, et al.Genome Med. 2010 Oct 5;2(10):73. doi: 10.1186/gm194.Genome Med. 2010.PMID:20923580Free PMC article.
References
- Pulley JM, Brace MM, Bernard GR, Masys DR. Attitudes and perceptions of patients towards methods of establishing a DNA biobank. Cell Tissue Bank. 2008; 9(1): 55–65. - PubMed
- Office for Human Research Protections, Department of Health and Human Services . Guidance on Research Involving Coded Private Information or Biological Specimens. Available at:http://www.hhs.gov/ohrp/humansubjects/guidance/cdebiol.pdf. Accessed February 1, 2010.
- Pulley JM, Brace M, Bernard GR, Masys D. Evaluation of the effectiveness of posters to provide information to patients about a DNA database and their opportunity to opt out. Cell Tissue Bank. 2007; 8: 233–241. - PubMed
- Kaufman D, Murphy J, Erby L, Hudson K, Scott J. Veterans’ attitudes regarding a database for genomic research. Genet Med. 2009; 11(5): 329–337. - PubMed
Publication types
MeSH terms
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical